These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38447198)

  • 1.
    Fang J; Zhang J; Meng L; Li H; Xia D; Wang Y; Chen H; Liao Z; Zhuang R; Li Y; Zhang X; Guo Z
    Mol Pharm; 2024 Apr; 21(4):1942-1951. PubMed ID: 38447198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of
    Liu H; Sun Y; Li J; Chen Y; Liu J; Fang J; Yang H; Feng L; Peng S; Zhuang R; Guo Z; Zhang X
    Mol Pharm; 2023 Jul; 20(7):3529-3538. PubMed ID: 37243620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel
    Fang J; Feng L; Meng L; Wang X; Liu H; Huang L; Zhang D; Li J; Zhuang R; Guo Z; Zhang X
    Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):27-37. PubMed ID: 36066666
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Gao F; Zhang Y; Chen M; Song Z; Dong R; Qiu S; Shen C; Huang X; Geng H; Cheng W; Hu J
    Eur J Pharm Sci; 2024 Feb; 193():106671. PubMed ID: 38104907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High in-vivo stability in preclinical and first-in-human experiments with [
    Qin X; Guo X; Liu T; Li L; Zhou N; Ma X; Meng X; Liu J; Zhu H; Jia B; Yang Z
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):302-313. PubMed ID: 36129493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated Synthesis and Preclinical Evaluation of Optimized Integrin α6-Targeted Positron Emission Tomography Imaging of Pancreatic Cancer.
    Chen L; Fu H; He H; Lou K; Li Q; Ye J; Feng G; Yu C
    Mol Pharm; 2023 Aug; 20(8):4277-4284. PubMed ID: 37463487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STING-driven interferon signaling triggers metabolic alterations in pancreas cancer cells visualized by [
    Liang K; Abt ER; Le TM; Cho A; Dann AM; Cui J; Li L; Rashid K; Creech AL; Wei L; Ghukasyan R; Rosser EW; Wu N; Carlucci G; Czernin J; Donahue TR; Radu CG
    Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34480004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First (18)F-labeled ligand for PET imaging of uPAR: in vivo studies in human prostate cancer xenografts.
    Persson M; Liu H; Madsen J; Cheng Z; Kjaer A
    Nucl Med Biol; 2013 Jul; 40(5):618-24. PubMed ID: 23602763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
    Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
    Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and preclinical evaluation of a novel molecular probe [
    Sun P; Mo C; Bai L; Wang M; Chen Z; Zhang M; Han Y; Liang H; Tang G
    Bioorg Chem; 2024 Apr; 145():107193. PubMed ID: 38442611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of STING probes and visualization of STING in multiple tumor types.
    Liu H; Liu J; Chen Y; Yang H; Fang J; Zeng X; Zhang J; Peng S; Liang Y; Zhuang R; Liu G; Zhang X; Guo Z
    Eur J Nucl Med Mol Imaging; 2024 Sep; ():. PubMed ID: 39289182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy.
    Zhu S; Liang B; Zhou Y; Chen Y; Fu J; Qiu L; Lin J
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):625-640. PubMed ID: 37878029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical Evaluation of
    Fang J; Wang X; Meng L; Zhang J; Zhuang R; Li Y; Zhang X; Guo Z
    ACS Pharmacol Transl Sci; 2024 Jun; 7(6):1783-1794. PubMed ID: 38898942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro and In Vivo Characterization of an
    Lütje S; Franssen GM; Herrmann K; Boerman OC; Rijpkema M; Gotthardt M; Heskamp S
    J Nucl Med; 2019 Jul; 60(7):1017-1022. PubMed ID: 30655329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of a (18)F-labeled high affinity NOTA conjugated bombesin antagonist as a PET ligand for GRPR-targeted tumor imaging.
    Varasteh Z; Aberg O; Velikyan I; Lindeberg G; Sörensen J; Larhed M; Antoni G; Sandström M; Tolmachev V; Orlova A
    PLoS One; 2013; 8(12):e81932. PubMed ID: 24312607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of caspase-responsive smart molecular probe for positron emission tomography imaging of drug-induced apoptosis.
    Qiu L; Wang W; Li K; Peng Y; Lv G; Liu Q; Gao F; Seimbille Y; Xie M; Lin J
    Theranostics; 2019; 9(23):6962-6975. PubMed ID: 31660080
    [No Abstract]   [Full Text] [Related]  

  • 17. Syntheses and preliminary evaluation of [(18) F]AlF-NOTA-G-TMTP1 for PET imaging of high aggressive hepatocellular carcinoma.
    Li Y; Zhang D; Shi Y; Guo Z; Wu X; Ren JL; Zhang X; Wu H
    Contrast Media Mol Imaging; 2016 Jul; 11(4):262-71. PubMed ID: 26931574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of [
    Wang M; Zhang H; Wang H; Feng H; Deng H; Wu Z; Lu H; Li Z
    Mol Pharm; 2018 Aug; 15(8):3093-3100. PubMed ID: 29889537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel aliphatic 18F-labeled probe for PET imaging of melanoma.
    Liu H; Liu S; Miao Z; Jiang H; Deng Z; Hong X; Cheng Z
    Mol Pharm; 2013 Sep; 10(9):3384-91. PubMed ID: 23927458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.
    Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
    Mol Pharm; 2016 May; 13(5):1520-7. PubMed ID: 27054811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.